Ozempic Babies and Ozempic Pregnancy Drug makers never tested GLP-1 drugs in pregnancy
(Switzerland) Altimmune (US) Glenmark Pharmaceuticals Ltd (India) Biocon (India) Teva Pharmaceuticals (Israel) MARKET SCOPE WHAT IS IN IT FOR YOU: GLP-1 Agonists Market REPORT CONTENT GUIDE DELIVERED CUSTOMIZATIONS We have successfully delivered the following deep-dive customizations: RECENT DEVELOPMENTS September 2025 : Novo Nordisk (Denmark) received EU approval for its oral GLP-1 receptor agonist drug, Rybelsus, to reduce cardiovascular death, heart attack, and stroke
His comprehensive understanding of the market ensures valuable contributions to research reports and business decisions
PMID: 17315030 Clemmons DR
M., Zdravkovic, M., & Bode, B
Additionally, it has shown potential in reducing liver fat content, which may benefit individuals with non-alcoholic fatty liver disease (NAFLD)